Biogen Inc. (NASDAQ:BIIB) shares were upgraded by analysts at Mizuho from Neutral to Buy rating while increasing their price target from $319 to $400.
Biogen, Inc. is a global biotechnology company, which focuses on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders.
Brokerage Firm Goldman upgraded Energy Transfer Equity L.P. (NYSE:ETE) shares from Neutral to Buy rating.
Energy Transfer Equity LP provides natural gas pipeline transportation and transmission services.
Investment Analysts at Citigroup upgraded Prudential Financial Inc. (NYSE:PRU) shares from Neutral to Buy rating.
Prudential Financial, Inc. provides financial products and services including life insurance, annuities, retirement-related services, mutual funds and investment management to individual and institutional customers through proprietary and third-party distribution networks.
Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/